Sales decline 12.13% to Rs 492.50 crore
Net profit of Natco Pharma declined 22.51% to Rs 62.30 crore in the quarter ended December 2022 as against Rs 80.40 crore during the previous quarter ended December 2021. Sales declined 12.13% to Rs 492.50 crore in the quarter ended December 2022 as against Rs 560.50 crore during the previous quarter ended December 2021. ParticularsQuarter EndedDec. 2022Dec. 2021% Var.Sales492.50560.50 -12 OPM %21.5018.16 -PBDT122.90127.00 -3 PBT81.4091.00 -11 NP62.3080.40 -23Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
